Evidence map›Paper›PMID 42168596›Full record

ArticleScientific reports2026

Expanding canonical cortical cell type markers in the era of single-cell transcriptomics.

Dennis M Joshy, Soojin V Yi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Dennis M JoshyDepartment of Mechanical Engineering, University of California, Santa Barbara, 93106, USA. dennis00@ucsb.edu.
Soojin V YiNeuroscience Research Institute, University of California, Santa Barbara, 93106, USA. soojinyi@ucsb.edu.

Funding

Cellular resolution multi-omics of white matter tracts in developing human and non-human primate brain for cell atlases-DiversityR01MH134809 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI WILLIAM D HOPKINS, Genevieve Konopka · 2024 to 2026
$4.2M
Comparative Epigenomics of Primate BrainsR01HG011641 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KONOPKA, GENEVIEVE, SHERWOOD, CHESTER · 2021 to 2024
$2.4M
National Institutes of Health,United States HG011641, MH134809National Science Foundation, United States EF-2021635NHGRI NIH HHS R01 HG011641NIMH NIH HHS R01 MH134809
6 · The paper itself

Abstract

Cell type markers have been instrumental to physiological and molecular investigation of the human brain and remain essential for annotating cell type clusters in single-cell expression data and for target validation studies. However, expression of canonical markers in the target cell type (which we termed as the expression 'fidelity') as well as expression in unrelated cell types (which we termed as the 'background expression') across cortical regions remains poorly characterized. Here, leveraging nearly 500,000 high-quality single-nucleus and single-cell profiles from 19 studies, we quantified marker fidelity, revealing substantial regional variability. We developed a statistical framework that aggregates annotated barcodes into pseudo-bulk profiles, applied rigorous performance metrics, and identified markers with high fidelity, low background, and consistent expression across regions. This approach extended the canonical marker set for six major brain cell types and yielded superior subtype-specific markers. The resulting marker lists, and a user-friendly analysis interface, provide a valuable resource for cell type annotation and validation in neuroscience research.

Indexed as

Cerebral CortexGene Expression ProfilingSingle-Cell AnalysisTranscriptomeBiomarkersHumansNeuronsSingle-Cell Gene Expression AnalysisBiomarkersBackground expressionCell type markersExpression fidelityHuman cortexScRNA-SeqSublayer specific markers

Identifiers

PMID42168596
PMCPMC13454430

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.